Pyrotinib Combined With Dalpiciclib Combined With Letrozole in ER-positive and HER2-positive Advanced Breast Cancer
NCT07014410
·
clinicaltrials.gov ↗
PHASE2
Phase
RECRUITING
Status
63
Enrollment
OTHER
Sponsor class
Conditions
Breast Cancer
Interventions
DRUG:
pyrotinib dalpiciclib letrozole
Sponsor
Zhejiang Cancer Hospital